Amends the Federal Food, Drug, and Cosmetic Act to include AI and machine learning technologies as eligible drug prescribers if they are state-authorized and FDA-approved, cleared, or authorized under specified sections.
Analysis summaries, actor details, and coverage mappings were LLM-classified and may contain errors.
This is a binding federal statute proposed to amend existing law (Federal Food, Drug, and Cosmetic Act) with mandatory legal obligations enforceable through existing FDA regulatory mechanisms.
The document has minimal coverage of AI risk domains, with brief implicit mentions of approximately 3-4 subdomains. The primary focus is on legal authorization for AI prescribers rather than risk mitigation. Limited implicit coverage relates to AI system safety (7.3), governance frameworks (6.5), and potentially human-computer interaction risks (5.1, 5.2).
This legislation primarily governs the Health Care and Social Assistance sector by authorizing AI/ML technologies to prescribe drugs. It also has implications for the Information sector (AI/ML technology developers) and Professional and Technical Services sector (healthcare IT systems). The Scientific Research and Development Services sector is implicitly governed through FDA approval requirements.
The document primarily addresses the Deploy stage by establishing legal authorization for AI/ML prescription technologies. It implicitly covers Verify and Validate through FDA approval requirements, and Operate and Monitor through ongoing state authorization requirements. The focus is on deployment authorization rather than development processes.
The document explicitly mentions both artificial intelligence and machine learning technologies as the systems being regulated. It does not specify particular AI types (frontier, general purpose, task-specific, etc.) or technical thresholds. The focus is on AI/ML systems capable of prescribing drugs.
United States Congress; Senate and House of Representatives of the United States of America
The document explicitly identifies Congress as the proposing body through the standard legislative enactment clause.
Food and Drug Administration (FDA); State authorities
The FDA is explicitly referenced as the federal enforcement body through its approval/clearance/authorization mechanisms under specific sections. State authorities are also enforcers through their statutory authorization requirements.
Food and Drug Administration (FDA); State authorities
The FDA and state authorities would monitor compliance through their existing regulatory oversight mechanisms for medical devices and practitioner licensing, though specific monitoring provisions are not detailed in this brief amendment.
The legislation targets entities that develop and deploy artificial intelligence and machine learning technologies for drug prescription purposes. These would be AI developers creating the prescription systems and healthcare deployers implementing them.
4 subdomains (4 Minimal)